IP
ZOM

Intellectus Partners’s Zomedica Corp. ZOM Stock Holding History

Intellectus Partners’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24,180
Closed -$5.12K – 283
2023
Q1 		$5.12K Hold
24,180
– – ﹤0.01% 253
2022
Q4 		$3.94K Hold
24,180
– – ﹤0.01% 260
2022
Q3 		$5K Sell
24,180
-7,000
-22% -$1.85K ﹤0.01% 260
2022
Q2 		$7K Hold
31,180
– – ﹤0.01% 250
2022
Q1 		$11K Hold
31,180
– – ﹤0.01% 233
2021
Q4 		$10K Hold
31,180
– – ﹤0.01% 269
2021
Q3 		$16K Buy
+31,180
New +$18.4K ﹤0.01% 272

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Intellectus Partners's ZOM Position: Q2 2023 in Review

Intellectus Partners sold out of Zomedica Corp. (ZOM) in Q2 2023, closing a stake of 24,180 shares — an estimated $5.12K sold.

Intellectus Partners first reported a position in ZOM in Q3 2021 and held it in 7 quarters. The position peaked at $16K in Q3 2021. 93 funds tracked by Wall St. Rank hold ZOM as of Q2 2023.

  • Intellectus Partners reported no remaining Zomedica Corp. position as of Q2 2023 after selling out during the quarter.
  • Intellectus Partners sold 24,180 Zomedica Corp. shares in Q2 2023, an estimated $5.12K.
  • Intellectus Partners first reported a position in Zomedica Corp. in Q3 2021 and held it in 7 quarters.
  • Intellectus Partners's Zomedica Corp. position peaked at $16K in Q3 2021.
  • 93 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2023.

Based on Intellectus Partners's 13F filing for Q2 2023, filed 31 Jul 2023.